121 related articles for article (PubMed ID: 15802053)
1. Imaging gene expression in regional brain ischemia in vivo with a targeted [111in]-antisense radiopharmaceutical.
Suzuki T; Zhang Y; Zhang YF; Schlachetzki F; Pardridge WM
Mol Imaging; 2004 Oct; 3(4):356-63. PubMed ID: 15802053
[TBL] [Abstract][Full Text] [Related]
2. Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology.
Suzuki T; Wu D; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
J Nucl Med; 2004 Oct; 45(10):1766-75. PubMed ID: 15471847
[TBL] [Abstract][Full Text] [Related]
3. Imaging gene expression in the brain in vivo in a transgenic mouse model of Huntington's disease with an antisense radiopharmaceutical and drug-targeting technology.
Lee HJ; Boado RJ; Braasch DA; Corey DR; Pardridge WM
J Nucl Med; 2002 Jul; 43(7):948-56. PubMed ID: 12097468
[TBL] [Abstract][Full Text] [Related]
4. Antisense imaging of gene expression in the brain in vivo.
Shi N; Boado RJ; Pardridge WM
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14709-14. PubMed ID: 11106372
[TBL] [Abstract][Full Text] [Related]
5. Drug targeting to the brain using avidin-biotin technology in the mouse; (blood-brain barrier, monoclonal antibody, transferrin receptor, Alzheimer's disease).
Jeong Lee H; Pardridge WM
J Drug Target; 2000; 8(6):413-24. PubMed ID: 11328667
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor radiopharmaceuticals: 111In chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics, and in vivo imaging of experimental brain tumors.
Kurihara A; Deguchi Y; Pardridge WM
Bioconjug Chem; 1999; 10(3):502-11. PubMed ID: 10346884
[TBL] [Abstract][Full Text] [Related]
7. Molecular imaging of bcl-2 expression in small lymphocytic lymphoma using 111In-labeled PNA-peptide conjugates.
Jia F; Figueroa SD; Gallazzi F; Balaji BS; Hannink M; Lever SZ; Hoffman TJ; Lewis MR
J Nucl Med; 2008 Mar; 49(3):430-8. PubMed ID: 18287262
[TBL] [Abstract][Full Text] [Related]
8. [Effects of electroacupuncture preconditioning on expression of nitric oxide synthase and glial fibrillary acidic protein in cortex of focal cerebral ischemia-reperfusion rats].
Zhang YG; Gong X; Hou LQ
Zhen Ci Yan Jiu; 2015 Apr; 40(2):113-8. PubMed ID: 26054195
[TBL] [Abstract][Full Text] [Related]
9. Delivery of a peptide radiopharmaceutical to brain with an IgG-avidin fusion protein.
Zhou QH; Lu JZ; Hui EK; Boado RJ; Pardridge WM
Bioconjug Chem; 2011 Aug; 22(8):1611-8. PubMed ID: 21707084
[TBL] [Abstract][Full Text] [Related]
10. P2X7 receptor expression after ischemia in the cerebral cortex of rats.
Franke H; Günther A; Grosche J; Schmidt R; Rossner S; Reinhardt R; Faber-Zuschratter H; Schneider D; Illes P
J Neuropathol Exp Neurol; 2004 Jul; 63(7):686-99. PubMed ID: 15290894
[TBL] [Abstract][Full Text] [Related]
11. Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter.
Zhang Y; Schlachetzki F; Zhang YF; Boado RJ; Pardridge WM
Hum Gene Ther; 2004 Apr; 15(4):339-50. PubMed ID: 15053859
[TBL] [Abstract][Full Text] [Related]
12. Antisense inhibition of delta-opioid receptor gene function in vivo by peptide nucleic acids.
Fraser GL; Holmgren J; Clarke PB; Wahlestedt C
Mol Pharmacol; 2000 Apr; 57(4):725-31. PubMed ID: 10727518
[TBL] [Abstract][Full Text] [Related]
13. Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo.
Pardridge WM; Boado RJ; Kang YS
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5592-6. PubMed ID: 7777554
[TBL] [Abstract][Full Text] [Related]
14. Sequential changes in glial fibrillary acidic protein and gene expression following parasagittal fluid-percussion brain injury in rats.
Dietrich WD; Truettner J; Zhao W; Alonso OF; Busto R; Ginsberg MD
J Neurotrauma; 1999 Jul; 16(7):567-81. PubMed ID: 10447069
[TBL] [Abstract][Full Text] [Related]
15. An antibody-avidin fusion protein specific for the transferrin receptor serves as a delivery vehicle for effective brain targeting: initial applications in anti-HIV antisense drug delivery to the brain.
Penichet ML; Kang YS; Pardridge WM; Morrison SL; Shin SU
J Immunol; 1999 Oct; 163(8):4421-6. PubMed ID: 10510383
[TBL] [Abstract][Full Text] [Related]
16. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
Goodwin DA; Meares CF; Osen M
J Nucl Med; 1998 Oct; 39(10):1813-8. PubMed ID: 9776294
[TBL] [Abstract][Full Text] [Related]
17. Targeted antisense radiotherapy and dose fractionation using a (177)Lu-labeled anti-bcl-2 peptide nucleic acid-peptide conjugate.
Liu D; Balkin ER; Jia F; Ruthengael VC; Smith CJ; Lewis MR
Nucl Med Biol; 2015 Sep; 42(9):704-10. PubMed ID: 26081917
[TBL] [Abstract][Full Text] [Related]
18. Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin.
Zhang Y; Pardridge WM
Brain Res; 2001 Jan; 889(1-2):49-56. PubMed ID: 11166685
[TBL] [Abstract][Full Text] [Related]
19. Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression.
Tyler BM; Jansen K; McCormick DJ; Douglas CL; Boules M; Stewart JA; Zhao L; Lacy B; Cusack B; Fauq A; Richelson E
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):7053-8. PubMed ID: 10359837
[TBL] [Abstract][Full Text] [Related]
20. [Effects of Electroacupuncture Intervention Combined with Gastrodin on Expression of Proteins Related to Proliferation-differentiation of Neural Stem Cells in Hippocampal CA 1 and CA 3 Regions in Focal Cerebral Ischemia Rats].
Li HB; Wu F; Xiong KR; Miao HC; Zhu XL
Zhen Ci Yan Jiu; 2015 Dec; 40(6):455-60. PubMed ID: 26887206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
